Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
| Autor: | Thatcher, Nick, Hirsch, Fred R, Luft, Alexander V, Szczesna, Aleksandra, Ciuleanu, Tudor E, Dediu, Mircea, Ramlau, Rodryg, Galiulin, Rinat K, Bálint, Beatrix, Losonczy, György, Kazarnowicz, Andrzej, Park, Keunchil, Schumann, Christian, Reck, Martin, Depenbrock, Henrik, Nanda, Shivani, Kruljac-Letunic, Anamarija, Kurek, Raffael, Paz-Ares, Luis, Socinski, Mark A |
|---|---|
| Zdroj: | In The Lancet Oncology July 2015 16(7):763-774 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|